Radiology Doctors in Fort Sam Houston, TX Accepting Medicare

27 Radiology doctors found. Showing 1 - 20

Dr. Michael Day Dullea, M.D. Radiology - Therapeutic Radiology Medicare: Medicare Enrolled Practice Location: 3851 Roger Brooke Dr, Mche-qd (credentials), Fort Sam Houston, TX 78234 Phone: 210-916-5046

Dr. Francis Joseph Cloran, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-916-4218

Dr. Jayanta Krishna Chaudhuri, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-539-9582

Dr. Anthony Wayne Allen, M.D. Radiology - Vascular & Interventional Radiology Medicare: Not Enrolled in Medicare Practice Location: 3851 Roger Brooke Dr, Brooke Army Medical Center Mche-qd/credentials, Fort Sam Houston, TX 78234 Phone: 210-916-3573

Dr. Aaron Jackson, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: Bamc- 3851 Roger Brooke Drive, Mche-qd, Fort Sam Houston, TX 78234 Phone: 210-916-2460

Dr. Shane Blake Anderson, D.O. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 3551 Roger Brooke Dr, Brooke Army Medical Center, Fort Sam Houston, TX 78234 Phone: 210-916-4062

Dr. Lisa M. Livingston, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-916-4218

Dr. Rebecca Ann Flores, D.O. Radiology - Diagnostic Radiology Medicare: Medicare Enrolled Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-539-9582

Dr. Paul Clark, D.O. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-539-0784

Dr. Carol Beth Gerza, M.D. Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 3851 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-916-2460

Norman J Arbelo Cruz, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 3851 Roger Brooke Dr, Diagnostic Radiology, Fort Sam Houston, TX 78234 Phone: 210-539-9582

Christopher Joseph Lisanti, M.D. Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-539-9582

Joshua Nielsen, MD Radiology - Nuclear Radiology Medicare: Not Enrolled in Medicare Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-916-4062

Dr. Steven Hoyt Craig, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 3851 Roger Brooke Dr, Mche-qd (creds), Fort Sam Houston, TX 78234 Phone: 210-916-2460

Sompong Nmn Singshinsuk, M.D. Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 3851 Roger Brooke Dr, Bamc Mche- Qd ( Creds ),, Fort Sam Houston, TX 78234 Phone: 210-916-2251

Dr. David Andrew Reynolds, D.O. Radiology - Vascular & Interventional Radiology Medicare: Accepting Medicare Assignments Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-916-3479

Dr. Penny Jean Vroman, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 952-595-1100    Fax: 612-294-4903

Scott G. Book, M.D. Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-539-9582    Fax: 210-916-1072

Corey O'reilly, MD Radiology - Diagnostic Radiology Medicare: Medicare Enrolled Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 253-968-0369

Augustah Jeremiah Poutre, M.D. Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-539-9582

News Archive

TSO3 new generation sterilizers allowed CE Mark labeling

TSO3 Inc., an innovator in sterilization technology for medical devices in healthcare settings using ozone, today announced that documentation supplied to the European Notified Body conforms to the new Medical Device Directive for Class IIb medical devices; an enhanced European standard to be enforced starting April 2010. This notification allows the Company to label its new generation sterilizers with the CE Mark, which is a requirement to place products in the European Union; the second largest sterilization market after the United States.

Seattle Genetics and Millennium announce positive data from SGN-35 Phase II trial in relapsed or refractory ALCL

Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced positive data from a phase II clinical trial of single-agent brentuximab vedotin (SGN-35) in relapsed or refractory systemic anaplastic large cell lymphoma (ALCL). Brentuximab vedotin is an antibody-drug conjugate (ADC) targeted to CD30, a defining marker of ALCL. The data were presented today during an oral session at the 52nd American Society of Hematology (ASH) Annual Meeting in Orlando, FL.

Policy developments: SCOTUS won't hear appeal of ruling striking down Okla. abortion law

The Supreme Court won't hear an appeal of a ruling striking down an Oklahoma abortion law that would have required pregnant women to have an ultrasound before having an abortion. In the meantime, The Washington Post fact-checks an insurance premium claim by HHS Secretary Sebelius.

Acceptance of initial regulatory filings for BMS-PCSK9Rx triggers $6M milestone payment to Isis Pharmaceuticals

Isis Pharmaceuticals, Inc. announced today that it has earned a $6 million milestone payment from Bristol-Myers Squibb Company related to the acceptance of initial regulatory filings to begin Phase 1 clinical studies for BMS-PCSK9Rx. BMS-PCSK9Rx is an antisense drug that arose out of the ongoing collaboration between Bristol-Myers Squibb and Isis to identify antisense drugs targeting PCSK9 to lower low-density lipoprotein (LDL) cholesterol.

Read more Medical News

› Verified 5 days ago

• 1(current)
• 2